Oral nirmatrelvir and ritonavir in nonhospitalized vaccinated patients with coronavirus disease 2019

S Ganatra, SS Dani, J Ahmad, A Kumar… - Clinical Infectious …, 2023 - academic.oup.com
Background Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk nonhospitalized unvaccinated patients reduced the risk of …
被引用次数：125 相关文章
[PDF] archive.org

[PDF][PDF] Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19

S Ganatra - 2022 - scholar.archive.org
ACCEPTED MANUSCRIPT Page 1 © The Author(s) 2022. Published by Oxford University
Press on behalf of Infectious Diseases Society of America. All rights reserved. For …

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

S Ganatra, SS Dani, J Ahmad, A Kumar… - Clinical Infectious …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus ritonavir (NMV-r) in …

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

S Ganatra, SS Dani, J Ahmad, A Kumar… - Clinical Infectious …, 2023 - academic.oup.com
Background Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk nonhospitalized unvaccinated patients reduced the risk of …
[PDF] pfizerpro.lt

[PDF][PDF] Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19

S Ganatra - 2022 - pfizerpro.lt
ACCEPTED MANUSCRIPT Page 1 © The Author(s) 2022. Published by Oxford University
Press on behalf of Infectious Diseases Society of America. All rights reserved. For …

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

S Ganatra, SS Dani, J Ahmad… - … publication of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk nonhospitalized unvaccinated patients reduced the risk of …

Oral nirmatrelvir and ritonavir in nonhospitalized vaccinated patients with Coronavirus disease 2019.

S Ganatra, SS Dani, J Ahmad, A Kumar, J Shah… - 2022 - cabidigitallibrary.org
Background: Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk nonhospitalized unvaccinated patients reduced the risk of …

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019.

S Ganatra, SS Dani, J Ahmad, A Kumar… - … Diseases: an Official …, 2023 - europepmc.org
Background Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk nonhospitalized unvaccinated patients reduced the risk of …

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019.

S Ganatra, SS Dani, J Ahmad… - Clinical Infectious …, 2023 - search.ebscohost.com
Background Treatment of coronavirus disease 2019 (COVID-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk nonhospitalized unvaccinated patients reduced the risk of …

Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19

S Ganatra, SS Dani, J Ahmad, A Kumar, J Shah… - … Infectious Diseases: An … - ncbi.nlm.nih.gov
Background Treatment of coronavirus disease-2019 (Covid-19) with nirmatrelvir plus
ritonavir (NMV-r) in high-risk non-hospitalized unvaccinated patients reduced the risk of …